Listeria monocytogenes is a human enteric pathogen that causes severe foodborne illness in high-risk populations. Crossing the intestinal barrier is the first critical step for Listeria monocytogenes infection. Therefore, reducing L. monocytogenes colonization and invasion of intestinal epithelium and production of virulence factors could potentially control listeriosis in humans. This study investigated the efficacy of sub-inhibitory concentration (SIC) of the plantderived antimicrobial eugenol, either alone, or in combination with five lactic acid bacteria (LAB), namely Bifidobacterium bifidum (NRRL-B41410), Lactobacillus reuteri (B-14172), Lactobacillus fermentum (B-1840), Lactobacillus plantarum (B-4496) and Lactococcus lactis subspecies lactis (B-633) in reducing Listeria monocytogenes adhesion to and invasion of human intestinal epithelial cells (Caco-2). Additionally, the effect of the aforementioned treatments on Listeria monocytogenes listeriolysin production, epithelial E-cadherin binding and expression of virulence genes was investigated. Moreover, the in vivo efficacy of eugenol-LAB treatments in reducing Listeria monocytogenes virulence in the invertebrate model Galleria mellonella was studied. Eugenol and LAB, either alone or in combination, significantly reduced Listeria monocytogenes adhesion to and invasion of intestinal cells (P < 0.05). Moreover, eugenol-LAB treatments decreased Listeria monocytogenes haemolysin production, E-cadherin binding and virulence gene expression (P < 0.05). In addition, the eugenol-LAB treatments significantly enhanced the survival rates of G. mellonella infected with lethal doses of Listeria monocytogenes (P < 0.05). The results highlight the antilisterial effect of eugenol either alone or in combination with LAB, and justify further investigations in a mammalian model.
INTRODUCTION
Listeria monocytogenes has emerged as one of the major foodborne pathogens responsible for causing listeriosis, a severe, invasive, multi-systemic infection, characterized by high hospitalization (90 %) and case fatality rates (20-30 %) (Cartwright et al., 2013; Rocourt & Brosch, 1992; Schuchat et al., 1991) . Being a foodborne pathogen, the gastrointestinal tract is the major portal of entry of Listeria monocytogenes in the host (V azquez-Boland et al., 2001; Farber & Peterkin, 1991) . In the human gastrointestinal tract, Listeria monocytogenes induces its own internalization without significantly affecting the host cellular architecture and crosses the intestinal epithelial barrier, either via direct invasion of enterocytes or through phagocytosis by the M cells of Peyer's patches (Marco et al., 1997; Corr et al., 2006) . Several virulence factors and transcriptional regulators critical for crossing the intestinal epithelium, for intracellular survival and for systemic spread in the host have been characterized in Listeria monocytogenes (V azquez-Boland et al., 2001) . These factors include internalins critical for intestinal invasion (Lingnau et al., 1995; Southwick & Purich, 1996) , listeriolysin O (LLO) required for intracellular survival (Greiffenberg et al., 1998; Smith-Palmer et al., 2002; Grundling et al., 2003; Marquis & Hager, 2000) , and actin polymerization protein ActA, essential for cell-to-cell spread (Alvarez-Domínguez et al., 1997; Kocks et al., 1992) . Thus, reducing Listeria monocytogenes invasion of host tissue and production of virulence factors that facilitate its intracellular survival and systemic spread could potentially control listeriosis in humans. Antibiotics are commonly used for the treatment of listeriosis; however, there have been recent reports of development of antibiotic resistance in Listeria monocytogenes (Krawczyk-Balska et al., 2012; Cekmez et al., 2012) . This increasing antibiotic resistance in Listeria monocytogenes and growing concerns over the reports of adverse drug reactions in patients (Thong & Tan, 2011) has ignited an interest in exploring the potential of various novel approaches as an alternative strategy to combat foodborne infections.
Since ancient times, plant extracts have been used as food preservatives and dietary supplements to prevent food spoilage and maintain human health. In addition, fermented foods containing beneficial microbiota have been a part of traditional diets for their health benefits. Eugenol (EG; 4-allyl-2-methoxyphenol) is a GRAS (Generally Recognized as Safe) status compound that is the active ingredient in the oil of clove (Eugenia caryophyllus). Various studies have highlighted the antioxidant, anti-inflammatory and anti-virulence properties of EG against several pathogens (Gill & Holley, 2004; Qiu et al., 2010) . The Food and Agriculture Organization (FAO) and World Health Organization (WHO) define probiotics as 'live microorganisms which when administered in adequate amounts confer a health benefit on the host'. Although several species of bacteria have been identified, the majority of probiotic bacteria supplemented in human diet belong to the lactic acid bacteria group (LAB), including lactobacilli and bifidobacteria. Interestingly, recent studies have shown that plant-derived antimicrobials that are highly bactericidal towards enteric pathogens exert low antimicrobial effect against commensal gut microbiota (Hawrelak et al., 2009; Di Pasqua et al., 2005) . Since EG and LAB exert their antimicrobial effects by different mechanisms (Shipradeep et al., 2012) , a combinatorial approach using EG and LAB could be more effective in controlling Listeria monocytogenes. However, studies elucidating their synergistic interactions on bacterial virulence are lacking.
The use of animal models to assess human listeriosis is critical for understanding the disease pathology and testing new therapies. Although appropriate mammalian models are primarily employed for such studies, their use poses significant practical, financial and ethical concerns. Insects are increasingly being used as surrogate hosts because they share with mammals the essential aspects of the innate immune response to microbial infections (Mukherjee et al., 2010; Seitz et al., 2003; Altincicek et al., 2007 Altincicek et al., , 2008 . Consequently, insect models have been proposed as cost-effective and easy alternatives that generate valid data on microbial virulence (Jander et al., 2000; Mylonakis et al., 2005) . Larvae of the greater wax moth (Galleria mellonella) have been used to study microbial pathogenesis in a wide array of organisms, including Pseudomonas aeruginosa (Jander et al., 2000; Miyata et al., 2003) , Burkholderia cepacia (Seed & Dennis, 2008) , Burkholderia mallei (Schell et al., 2008) , Bacillus cereus (Fedhila et al., 2006) , Acinetobacter baumannii (Peleg et al., 2009) , Klebsiella pneumoniae (Insua et al., 2013) , several pathogenic fungi (Cotter et al., 2000; Mylonakis et al., 2005; Reeves et al., 2004) and Listeria monocytogenes (Joyce et al., 2010; Mukherjee et al., 2010 Mukherjee et al., , 2011 .
The present study investigated the efficacy of sub-inhibitory concentrations (SICs, compound concentrations not inhibitory to bacterial growth) of EG, either alone or in combination with five LAB, namely Bifidobacterium bifidum (NRRL-B41410), Lactobacillus reuteri (B-14172), Lactobacillus fermentum (B-1840), Lactobacillus plantarum (B-4496), or Lactococcus lactis subspecies lactis (B-633) in reducing Listeria monocytogenes adhesion to and invasion of human intestinal epithelial cells (Caco-2), and production of virulence factors in vitro. In addition, the in vivo efficacy of EG-LAB treatments in reducing Listeria monocytogenes virulence in the invertebrate model, G. mellonella was investigated.
METHODS

Bacterial strains and growth conditions
All bacteriological media were purchased from Difco (Becton Dickinson). Three strains of Listeria monocytogenes, including ATCC 19115 (serotype 4b), Scott A (serotype 4b) and Presque-598, and five probiotic bacteria, namely Bifidobacterium bifidum (NRRL-B41410), Lactobacillus reuteri (B-14172), Lactobacillus fermentum (B-1840), Lactobacillus plantarum (B-4496) and Lactococcus lactis subspecies lactis (B-633) from our culture collection were used in this study. Each Listeria monocytogenes strain was cultured separately in 10 ml sterile tryptic soy broth with 0.6 % (w/v) yeast extract (TSBYE) in 50 ml screw-cap tubes, and incubated at 37
C for 24 h. Following incubation, the cultures were sedimented by centrifugation (3600 g for 15 min) at 4 C. The pellet was washed twice, resuspended in 10 ml sterile PBS (pH 7.0), and serial tenfold dilutions were cultured on duplicate tryptic soy agar (TSA) and modified Oxford agar plates, followed by incubation at 37 C for 48 h. The LAB were cultured in de Man-Rogosa-Sharpe (MRS) broth supplemented with 0.05 % (w/v) L-cysteine hydrochloride (Sigma-Aldrich), and incubated in an anaerobic incubator maintained at microaerophilic conditions (88 % nitrogen, 10 % carbon dioxide, 2 % oxygen) at 37 C for 24 h. Following incubation, the probiotic cultures were serially diluted in PBS and plated on MRS agar plates, followed by incubation at 37 C for 48 h for bacterial enumeration.
Determination of SIC of EG and LAB culture supernatant
The SIC of EG against Listeria monocytogenes was determined using a standard protocol (Amalaradjou et al., 2011; Johny et al., 2010) . Sterile 24-well polystyrene plates (Costar, Corning) containing TSBYE (1 ml per well) were inoculated with~6.0 log c.f.u. of Listeria monocytogenes, followed by the addition of 0.1-10 µl EG (99 % purity, Sigma-Aldrich) with an increment of 0.5 µl. The plates were incubated at 37 C for 24 h, and bacterial growth was determined by culturing on modified Oxford agar plates. For establishing the SICs of LAB culture supernatant against Listeria monocytogenes, the cell-free LAB culture supernatant was serially diluted (100, 50, 25, 12.5 and 6.25 %) in 100 µl MRS broth, followed by addition of equal volume of TSBYE containing~10
6 Listeria monocytogenes. The plates were incubated as described above, followed by bacterial enumeration. The highest concentration of EG or LAB culture supernatant that did not inhibit Listeria monocytogenes growth after incubation for 24 h was selected as its respective SIC for this study.
Adhesion and invasion assay. The effect of SIC of EG either alone or in combination with each LAB on Listeria monocytogenes adhesion and invasion of Caco-2 cells was determined as previously reported for bacteriocin-producing strains (Moroni et al., 2006) . Monolayers of Caco-2 cells were grown in 24-well tissue culture plates (Costar) at~10 C for 1 h in a humidified 5 % CO 2 incubator. For the adhesion assay, the infected monolayers were rinsed three times in PBS after incubation for 1 h, and the cells were lysed with 0.1 % Triton X-100 (Invitrogen). The number of viable adherent Listeria monocytogenes was determined by serial dilution and culturing on TSA and modified Oxford agar plates. For the invasion assay, the Caco-2 monolayer after 1 h of incubation following Listeria monocytogenes inoculation was rinsed three times in minimal medium and incubated for another 2 h in cell culture medium containing gentamicin (100 µg ml -1 ) (Invitrogen) to kill the extracellular bacteria. Subsequently, the wells were washed three times with PBS, followed by addition of 1 ml PBS containing 0.1 % Triton X-100 and incubation at 37 C in 5 % CO 2 for 15 min to lyse the eukaryotic cells and release the intracellular Listeria monocytogenes. The cell lysates were serially diluted, cultured on TSA and modified Oxford agar plates, and incubated at 37 C for 24-48 h before bacterial enumeration.
E-Cadherin binding assay
This assay was conducted as described previously, with slight modifications (Tzouvelekis et al., 1991; Prakash et al., 2011) . Briefly, microtitre plates (Corning, Costar) were coated with human recombinant E-cadherin (5 µg per well; Advanced Biomatrix) suspended in coating buffer (KPL), and incubated overnight at 4 C. The unbound E-cadherin was removed by three washes using washing buffer (KPL). Residual binding sites were blocked with PBS-2 % BSA and incubation at 37
C for 1 h. After removing unbound BSA by three washes with washing buffer, Listeria monocytogenes (~9 log c.f.u.) was added to each well either alone (control) or with SICs of EG and LAB (~9 log c.f.u.) and incubated at 37 C for 4 h. The unbound bacteria were removed by washing three times with wash buffer. One hundred microlitres of mouse monoclonal antibody (1 : 100 in PBS-1 % BSA; Pierce Thermo Scientific) against Listeria monocytogenes was added to each well and incubated at 37
C for 1 h. The unbound antibody was removed by washing three times. Subsequently, 100 µl of anti-mouse HRP-conjugated secondary antibody (1 : 2000 in PBS-1 % BSA; KPL) was added to each well and incubated at 37 C for 1 h. The unbound antibody was removed by washing three times with washing buffer. The wells were then incubated in the dark with 100 µl substrate-H 2 O 2 for 15 min. The reaction was arrested by the addition of 100 l of 1 M H 2 SO 4 , and the colour developed was measured at 450 nm in a micro plate reader. All experiments were done in triplicate and repeated three times. Specific binding to E-Cadherin was calculated by subtracting the value of bacteria bound to BSA from the values of bacteria bound to E-Cadherin. A value of 0.2 was used as an indicator of specific binding (Prakash et al., 2011) .
Haemolysis assay
Listeriolysin O activity in the supernatant of Listeria monocytogenes culture grown in the presence or absence of SICs of EG either alone or in combination with LAB culture supernatant was quantified by haemolysis assay (Sampathkumar et al., 1998; Smith-Palmer et al., 2002) . Briefly, an overnight culture (10 ml) of Listeria monocytogenes was centrifuged at 4000 g for 10 min and washed three times with PBS. The washed pellet was diluted appropriately and resuspended in TSBYE (10 ml) at a concentration of~6.0 log c.f.u. ml
À1
, and incubated with or without the SICs of EG-LAB supernatant at 37 C for 12 h. One millilitre of a 12 h Listeria monocytogenes culture was centrifuged at 12 000 g in 1.5 ml sterile tubes, and the supernatant was collected. Defibrinated sheep blood (Quad five) was centrifuged at 600 g for 10 min and the supernatant was discarded. Sheep red blood cells (SRBC) were washed three times and resuspended at 3 % concentration in PBS. Serial 2-fold dilutions were made by mixing 100 µl Listeria monocytogenes culture supernatant with 100 µl PBS, and 100 µl freshly prepared 3 % SRBC was added to each well. The plates were incubated for 30 min at 37 C. Saline controls (0 % haemolysis) obtained by addition of 100 µl PBS to 100 µl of 3 % SRBC, and positive haemolysis controls (100 % haemolysis) obtained by addition of 100 µl sterile distilled water and 100 µl of 3 % SRBC were also included for appropriate comparison. The pellets in the microtitre plate were mixed using a vortex mixer, the absorbance was measured at 600 nm and percentage haemolysis was estimated according to the formula % haemolysis = (1 À A s /A t ) Â 100, where A s refers to the differences in absorbance (600 nm) between the sample and positive control, and A t refers to the difference in absorbance (600 nm) between the saline control and positive control, respectively (Bhakdi et al., 1984) .
RNA isolation and real-time quantitative PCR
The effect of EG alone or in combination with LAB supernatants on the expression of Listeria monocytogenes virulence genes was investigated using RT-qPCR, as described previously (Ollinger et al., 2009) . Each Listeria monocytogenes strain was grown separately with the respective SICs of EG, LAB supernatants or their combinations at 37 C in TSBYE to mid-log phase (8 h), and total RNA was extracted using RNeasy RNA isolation kit (Qiagen). Complementary DNA (cDNA) synthesis was performed using the Superscript reverse transcriptase kit (Invitrogen). The cDNA synthesized was used as the template for RT-qPCR. The amplification product was detected using SYBR Green reagents. The primers for each gene (Table 1) were designed from published GenBank database sequences of Listeria monocytogenes EGDe (serotype 1/2a) using Primer Express software (Applied Biosystems). Primer set amplification specificity was tested using NCBI primer-BLAST, melt curve analysis and in silico PCR amplification (Bikandi et al., 2004) . Relative gene expression was determined using the comparative critical threshold (Ct) realtime PCR using a 7500
Step one Real Time PCR system (Applied Biosystems). Data were normalized to the endogenous control (16S rRNA), and the level of candidate gene expression between treated and untreated samples was compared to study relative gene expression, and the effect of EG-LAB treatments on each gene.
In vivo studies using Galleria mellonella larva Larvae of the greater wax moth, Galleria mellonella in the final-instar stage (Mealworms by the pound, Boerne, TX) were maintained in the dark at room temperature, and used within 7 days from shipment. Prior to an experiment, ten larvae were randomly selected and sacrificed to confirm that the larvae were initially devoid of Listeria monocytogenes.
Galleria mellonella injection and determination of Listeria monocytogenes infectious dose. G. mellonella injections were carried out using a standard protocol (Mylonakis et al., 2005; Peleg et al., 2009) . Three strains (Scott A, 19115 and Presque-598) of Listeria monocytogenes were washed and resuspended separately in PBS at appropriate cell density, as described previously. Five microlitres of bacterial inocula (10 7 to 10 3 c.f.u. per larvae) were injected dorsolaterally into the haemocoel of last-instar larvae using a Hamilton syringe (capacity 50 µl; 24 G; point style 2 with beveled tip). After injection, the larvae were incubated at 37 C in sterile petri dishes supplemented with sterile bedding material, and the number of dead larvae was scored at 24 h intervals for 7 days. Larvae were considered dead when they displayed no movement in response to touch. For all experiments, the following control groups were used: negative control (larvae inoculated with PBS), trauma control (larvae administered blank injection to monitor killing due to physical trauma) and positive control (larvae inoculated with Listeria monocytogenes). In addition, treatment control groups were maintained to ensure that the EG-LAB supernatant treatments were not lethal to the larvae.
G. mellonella survival assay. The efficacy of SICs of EG and LAB culture supernatant alone or in combination in protecting G. mellonella against Listeria monocytogenes was investigated according to a previously published protocol (Mukherjee et al., 2010) . Six separate experiments were conducted, wherein 10 G. mellonella larva each (150-200 mg) were randomly allocated to different EG-LAB treatment groups, and injected with 5 µl PBS containing EG, LAB culture supernatants or combination, followed by Listeria monocytogenes inoculation (5 µl volume; 5 log c.f.u. per larvae). After injection, the larvae were incubated at 37 C in the dark, and the larval death time was recorded for a period of 7 days at 24 h intervals.
G. mellonella antimicrobial peptide assay. The effect of EG, LAB culture supernatant or their combination on the expression of antimicrobial peptides (gallerimycin, lysozyme) of G. mellonella was investigated using RT-PCR, as described previously (Mukherjee et al., 2010) . Groups of 10 larva each were injected with SIC concentrations of EG, either alone or in combination with LAB culture supernatant. After 1 h of incubation at 37 C, the larvae were challenged with Listeria monocytogenes (5 log c.f.u. per larva) and incubated for 24 h. At 6 h post Listeria monocytogenes inoculation, three larvae from each treatment group were homogenized in 1 ml Trizol reagent (Sigma), and whole insect RNA was extracted according to the manufacturer's recommendations. Quantitative real-time RT-PCR was performed using specific published primers (Altincicek & Vilcinskas, 2006;  
Statistical analysis
A completely randomized design with factorial treatment structure was used for the study. The factors included EG, LAB/culture supernatants, or their combinations. All experiments had duplicate samples and were repeated three times. For each treatment and control, the data from independent replicate trials were pooled and analysed using the PROC MIXED subroutine of the Statistical Analysis Software (SAS ver. 9.2; SAS Institute). Data comparisons for the gene expression study were made by using Student's t-test. Differences were considered significant when the P value was < 0.05. For the larvae experiments, all statistical analyses were performed using GraphPad Prism v.6.0 (GraphPad Software). The log-rank test was used to analyse survival curves, with a P -value of < 0.05 indicating statistical significance. All G. mellonella experiments were performed at least six times. 
RESULTS
Since the results from the tests conducted were not significantly different among the three Listeria monocytogenes strains studied (P > 0.05), only the results obtained with strain Scott A are presented here.
Determination of SICs of EG and LAB culture supernatant
The highest SIC of EG that did not inhibit Listeria monocytogenes growth as compared to control was 0.04 % (2.5 mM). The aforementioned concentration of EG was not inhibitory to the growth of LAB (data not shown). Similarly, since 12.5 % of cell-free LAB culture supernatant was found to be sub-inhibitory to the growth of Listeria monocytogenes, it was selected for further experiments. The SIC of EG or LAB culture supernatants either alone or in combination did not change the pH of the culture media (P > 0.05).
Effect of SICs of EG either alone or in combination with LAB on Listeria monocytogenes adhesion to and invasion of Caco-2 cells
The efficacy of EG either alone or in combination with LAB in reducing Listeria monocytogenes adhesion and invasion of Caco-2 cells is presented in Fig. 1 . Results revealed that EG and LAB either alone or in combination significantly reduced Listeria monocytogenes adhesion to and invasion of Caco-2 cells, compared to controls. The single treatment of EG or LAB reduced Listeria monocytogenes adhesion to (Fig. 1a) and invasion of (Fig. 1b) Caco-2 cells by~1.5 to 2 log c.f.u. (P<0.05). However, the combination treatments of EG and LAB were more effective in reducing the adhesion-invasion capacity of Listeria monocytogenes than the single treatments. The combination treatment of EG and LAB (B. bifidum, Lactobacillus reuteri, Lactobacillus plantarum), decreased adhesion by~2.5 log c.f.u. (Fig. 1a) , and all combinations completely inhibited Listeria monocytogenes invasion to Caco-2 cells (Fig. 1b) (P<0.05) .
Effect of SICs of EG either alone or in combination with LAB on Listeria monocytogenes binding to human epithelial Ecadherin
The binding of increasing concentrations of Listeria monocytogenes to E-cadherin is presented in Fig. 2 . The binding of Listeria monocytogenes to E-Cadherin was concentrationdependent, and maximum binding of Listeria monocytogenes (9 log c.f.u. per well) to E-cadherin was equivalent tõ 0.35 absorbance units (Fig. 2 ). G and LAB treatments, either alone or in combination reduced Listeria monocytogenes binding to E-cadherin by~0.15 absorbance units ( Fig. 3; P<0.05) , which corresponded to a reduction in binding of~2 log c.f.u. Listeria monocytogenes per well (Prakash et al., 2011) . However, the combination treatments did not differ significantly in their efficacy for reducing Listeria monocytogenes binding to E-cadherin compared to the corresponding single EG or LAB treatments (P>0.05).
Effect of SICs of EG either alone or in combination with LAB supernatant on Listeria monocytogenes haemolysin production G and LAB culture supernatants either alone or in combination reduced Listeria monocytogenes haemolysin production (Fig. 4) compared to controls (P<0.05). However, the magnitude of reduction was found to be greater in EG treatments compared to LAB supernatants (P<0.05). For example, EG reduced haemolysin production by >60 %, whereas the maximum reduction in haemolysin production due to LAB supernatant treatments was~30 %. The combination treatments of 0.04 % EG with Lactobacillus reuteri, Lactobacillus fermentum, Lactobacillus plantarum and Lactococcus lactis were more effective than single treatments of plant compound or LAB and reduced haemolysin production to approximately 15 % (P<0.05).
Effect of SICs of EG and LAB supernatants on expression of Listeria monocytogenes virulence genes and G. mellonella antimicrobial peptide genes
Real-time quantitative PCR results revealed that EG (0.04 %) either alone or in combination with LAB culture supernatants (12.5 %) down-regulated the expression of the (Tables 2 and 3 ). In general, the magnitude of down-regulation was greater in combination treatments as compared to single EG or LAB treatment (P<0.05). Similarly, RT-qPCR results revealed that EG, LAB supernatants and their combinations significantly up-regulated the expression of G. mellonella genes encoding the antimicrobial peptides, gallerimycin and lysozyme in infected larvae (Tables 6  and 7 ). The expression of antimicrobial peptide genes in uninfected larvae (Tables 4 and 5 ) was not significantly affected by majority of treatments (P<0.05). It was also observed that the combination of EG with B. bifidum supernatant was more inhibitory on the aforementioned genes than the EG or LAB treatment alone (P<0.05).
majority of virulence genes of Listeria monocytogenes
Effect of EG and LAB culture supernatant on G. mellonella survival
The inoculation of G. mellonella with Listeria monocytogenes resulted in a dose-dependent killing of the larvae (Fig. 5a ) (P<0.05). For example, 100 % of G. mellonella larvae were killed within 24 h of infection with~7 log c.f.u. Listeria monocytogenes per larva, whereas only 10 % mortality was recorded at 24 h in the group inoculated with 4 log c.f.u. 
Listeria monocytogenes per larva (P<0.05). A moderate
Listeria monocytogenes infectious dose of 5 log c.f.u. per larva that resulted in 100 % mortality by 5 days was selected as the challenge dose for subsequent experiments. The SIC of EG significantly enhanced the survival rates of infected G. mellonella larvae by at least 40 % on day 7 (P<0.05). Similar to EG, the cell-free supernatants from all the five LAB increased the larval survival by at least 30 % on day 7 compared to controls (Fig. 5b) . Amongst the various treatments, B. bifidum supernatant (12.5 %) was most effective in protecting the larvae, where~60 % survival was observed. The combination treatment of EG and B. bifidum supernatant was more effective in protecting G. mellonella against Listeria monocytogenes than the single treatments of EG or supernatant and resulted in 65 % survival rates in worms (P<0.05) (Fig. 5c) .
DISCUSSION
This study investigated whether the plant-derived antimicrobial EG, either alone or in combination with LAB, reduces the virulence of Listeria monocytogenes. It was observed that exposure of Listeria monocytogenes to EG-LAB treatments reduced virulence of the pathogen by decreasing the expression of virulence genes and production of virulence factors such as motility, cell invasion and listeriolysin production in vitro. In addition, the aforementioned treatments were effective in vivo, as evident from the enhanced survival of Listeria monocytogenes-infected G. mellonella larvae.
Being a foodborne pathogen, crossing the intestinal epithelium is the first critical step in Listeria monocytogenes infection in humans that is followed by colonization of the liver, spleen and systemic spread to various internal organs, leading to meningitis and placental infections in susceptible individuals and pregnant women, respectively (Portnoy et al., 2002) . This is mediated by several virulence factors that contribute to various stages of Listeria monocytogenes pathophysiology inside the host. Reducing Listeria monocytogenes invasion of intestinal epithelium and production of virulence factors can potentially reduce the risk of infection. Our results revealed that EG and LAB reduced the attachment and invasive abilities of the pathogen on intestinal epithelial cells (Fig. 1a, b) . Dutra & coworkers (2015) had similar findings and observed that pre-exposure of HT-29 cells to lactic acid bacteria (Lactobacillus casei, Lactobacillus rhamnosus) significantly reduced Listeria monocytogenes attachment (10-13 %) and invasion (40-50 %) to the cells, indicating that LAB are effective in reducing Listeria monocytogenes colonization both when administered prophylactically and during infection. Adhesion to and internalization of Listeria monocytogenes within epithelial cells is mainly mediated by two bacterial surface proteins, internalin A (InlA) and internalin B (InlB) that bind to host cell receptors E-cadherin and Met, respectively (Lingnau et al., 1995; Bonazzi et al., 2009) . Since the bacterial binding assay revealed that EG and LAB significantly reduced the binding of Listeria monocytogenes to E-cadherin, the decreased pathogen attachment and invasion in cell culture assays could partially be attributed to its decreased binding to the receptor and competitive exclusion by LAB. After receptor-mediated internalization in the intestinal epithelium, Listeria monocytogenes is engulfed in an intracellular phagosome, from where the pathogen escapes into the cell cytoplasm by disrupting the phagosomal membrane (Gaillard et al., 1991; Kreft & Vazquez-Boland, 2001 ). This is mediated by pore-forming toxin, listeriolysin O (V azquez -Boland et al., 2001; Smith-Palmer et al., 2002; Birmingham et al., 2007) . G either alone or in combination with LAB culture supernatants significantly decreased the production of listeriolysin O by the pathogen, as evident from the diminished haemolysis of sheep RBC (Fig. 4) .
It has been shown that the sub-lethal or sub-inhibitory concentrations of antimicrobials, including antibiotics modulate bacterial gene transcription (Goh et al., 2002; Tsui et al., 2004) . We previously observed that SICs of trans-cinnamaldehyde (TC), carvacrol (CR) and thymol (TY) inhibited virulence properties of Listeria monocytogenes (Upadhyay et al., 2012) . Additionally, the SICs of TC were found to suppress attaching and invading abilities of uropathogenic Escherichia coli in human urinary tract epithelial cells, by down-regulating the genes critical for host tissue colonization (Amalaradjou et al., 2010) . Since the SICs of EG and LAB culture supernatants were used in the experiments, the reduction observed in Listeria monocytogenes virulence properties was not due to the killing of the bacterium by the plant compound and LAB, but could be attributed to their potential effect in modulating the expression of virulence genes associated with its pathogenesis. Therefore, we used real-time quantitative PCR (RT-qPCR) to determine the effect of EG and LAB culture supernatants on the transcription of major genes that we are previously reported to play a role in Listeria monocytogenes virulence and infection in humans. Of the various regulatory proteins, the transcriptional modulator PrfA positively regulates the expression of genes coding for Listeria monocytogenes virulence, thus contributing to infection in the host (Brehm et al., 1996; Renzoni et al., 1997) . The gene lmo1847 transcribes Listeria adhesion binding protein, which plays a role in Listeria monocytogenes adhesion to host tissue (Pandiripally et al., 1999; Reis et al., 2010) . Similarly, inlA, inlB and iap also encode for proteins assisting in Listeria monocytogenes invasion of host tissue (Cabanes et al., 2004; Gaillard et al., 1991; Park et al., 2000) . The gene hly encodes listeriolysin production, while plcA, plcB genes produce phospholipase (V azquez- Boland et al., 2001) . Genes hly and plcA,B along with dnaK (encodes major stress protein DnaK) are critical for phagosomal escape and intracytoplasmic survival. Once free in the cytoplasm of the host cell, Listeria monocytogenes uses the protein ActA to harness the host cell's actin polymerization machinery and facilitate its intracellular movement and cell-to-cell spread in the host tissue (Alvarez-Domínguez et al., 1997; Kocks et al., 1992; Lambrechts et al., 2008) . RT-qPCR results revealed that the EG and LAB supernatant either alone or in combination significantly down-regulated the expression of the majority of the aforementioned virulence genes compared to the control (Tables 2 and 3 ). However, the magnitude of down-regulation of the genes brought by the various treatments differed with EG and LAB combination. For example, 0.04 % EG down-regulated the expression of inlA by approximately 5-fold, whereas the magnitude of down-regulation due to the combination of 0.04 % EG with B. bifidum supernatant was approximately 10-fold (Tables 2 and 3) . Similarly, Lactobacillus plantarum culture supernatant (12.5 %) reduced the expression of inlA by nearly 5-fold compared to other LAB treatments, which reduced the expression by only 1 to 2- (Table 2 ). This suggests that the EG and LAB may act through different mechanisms. Among the probiotic bacteria, since B. bifidum was generally more inhibitory on the various virulence factors tested, it was used in further experiments in combination with EG. The combination treatments containing EG and B. bifidum supernatant were found to be significantly more effective in down-regulating the expression of critical virulence genes compared to EG or supernatant alone (Tables 2 and 3 influencing gut microbiota physiology (Brown et al., 2012) and composition (Ley et al., 2006; Duncan et al., 2007) , which in turn has been associated with attenuated pathogen virulence and reduced susceptibility of the host to foodborne infections (Dominguez-Bello & Blaser, 2008; Ghosh et al., 2011) . Bomba & coworkers (2002) observed that the administration of polyunsaturated fatty acids positively influenced the adhesion of Lactobacillus spp. to the jejunal mucosa of gnotobiotic piglets, suggesting that intake of such fatty acids may influence the intestinal levels of beneficial gut microbiota (Bomba et al., 2002) . In another study, low dose of dietary resveratrol, a potent antioxidant found in grapes, was found to increase the counts of Bifidobacterium and Lactobacillus spp. in the colon microbiota of rats (Larrosa et al., 2009) . These studies suggest that plantderived antimicrobials, in addition to exerting a direct inhibitory effect on foodborne pathogens, may potentiate probiotic bacteria in conferring protection to the host. Another mechanism by which the EG-LAB interaction could confer an enhanced protection against pathogens is by the action of probiotic bacteria on the bioavailability and chemical transformation of plant compounds (Aura, 2008) . The microbiota-mediated metabolites of polyphenols are better absorbed in the intestine, leading to prolonged entero-hepatic circulation, and resident time in the plasma and gut, thereby enhancing their antimicrobial efficacy (Laparra & Sanz, 2010) . However, in-depth research is needed to fully elucidate the interactive mechanisms behind the enhanced anti-virulence effect of plant-derived antimicrobials and probiotic bacteria.
The innate immunity of Galleria is a multi-component response involving haemolymph coagulation, cellular phagocytosis and phenol oxidase-based melanization. Additionally, killing of pathogens in G. mellonella is achieved similar to that in mammals, i.e. by lysozymes, reactive oxygen species and antimicrobial peptides such as gallerimycin (Mukherjee et al., 2010) . Therefore we utilized G. mellonella as an in vivo model to determine the efficacy of EG and LAB in attenuating Listeria monocytogenes virulence. The results from G. mellonella survival curves revealed that although EG and LAB supernatants were effective in protecting the larvae from Listeria monocytogenes compared to control (P<0.05), the combination of EG with B. bifidum supernatant resulted in an enhanced larval survival compared to the single treatment of EG or LAB supernatant (Fig. 5c ). Since G. mellonella's innate immune response against pathogens includes the production of lysozyme and gallerimycin, we determined the effect of EG and LAB treatments on the expression of genes encoding these defensins in the larvae. The RT-qPCR data from G. mellonella gene expression revealed that EG, LAB supernatants (except Lactobacillus plantarum), and their combinations significantly up-regulated G. mellonella genes encoding lysozyme and gallerimycin, which could have played a role in increasing the survival of infected larvae compared to control.
In conclusion, this study demonstrated that EG, LAB, and their combinations were effective in significantly reducing the virulence properties of Listeria monocytogenes in vitro and in vivo. To the best of our knowledge, this is the first study investigating the synergistic antimicrobial effects of plant compound and LAB in attenuating Listeria monocytogenes virulence. G and LAB could potentially be used as an oral supplement to control Listeria monocytogenes infection. However, additional in vivo studies in an appropriate mammalian model are necessary to validate the efficacy and safety of the aforementioned treatments.
